VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2020 | FLIPPER trial: an update

Joan Albanell, MD, Pompeu Fabra University, Barcelona, Spain, discusses the results from the FLIPPER trial (NCT02690480). The FLIPPER trial is a randomized Phase II study that investigated the efficacy of fulvestrant plus palbociclib vs fulvestrant plus placebo in postmenopausal women with hormone receptor positive (HR+)/HER2 negative (HER2–) endocrine-sensitive advanced breast cancer (ABC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter